Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease

OBJECTIVE: Depressive and anxiety symptoms could affect the quality of life and prognostic outcomes in chronic kidney disease (CKD) patients, but only a few studies focus on the interventions to manage or prevent these symptoms in CKD patients. Therefore, this study was conducted to compare the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jian-wei, Xie, Shu-qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818845/
https://www.ncbi.nlm.nih.gov/pubmed/29497298
http://dx.doi.org/10.2147/NDT.S159636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818845/
https://www.ncbi.nlm.nih.gov/pubmed/29497298
http://dx.doi.org/10.2147/NDT.S159636

Ejemplares similares